| Authors: |
Solomon I; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Rybak C; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Van Tongeren L; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Kuzmich L; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Blazer K; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Nehoray B; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Niell-Swiller M; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA., Bray S; Hereditary Colon Cancer Foundation, Portland, OR, USA., Bray TH; Hereditary Colon Cancer Foundation, Portland, OR, USA., Hurley K; Cleveland Clinic, Cleveland, OH, USA., Weitzel JN; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA. jweitzel@coh.org., Slavin TP; City of Hope, Division of Clinical Cancer Genomics, Duarte, CA, USA. tslavin@coh.org. |
